Literature DB >> 23994827

Effect of serum lipoproteins and cholesterol on an exogenous pulmonary surfactant. ESR analysis of structural changes and their relation with surfactant activity.

María Martínez Sarrasague1, Alejandra Cimato, Lidia Piehl, Fernando Brites, Graciela Facorro.   

Abstract

The study of structural changes in the surfactant may help to understand the mechanisms by which the surfactant is inactivated by serum. Here, we compared the in vitro effects of serum, albumin, lipoproteins (VLDL, LDL, HDL) and cholesterol on the dynamic and structural properties of surfactant suspensions by electronic spin resonance and surface tension measurements. Our results showed that albumin seems to be responsible for macrostructure disaggregation and increased rigidity in the hydrophobic region, but it did not affect surfactant activity. Fluidity in the polar area seems to be critical for proper physiological activity, and the changes induced by serum observed in this area would be generated by HDL or cholesterol, but the amount of cholesterol transferred by serum is not significant. Statistical analysis showed that surfactant activity correlated with the fluidity in the polar area but not with that in the hydrophobic region. We obtained strong evidence that among all the serum components tested, HDL is the one that causes the structural changes that compromise surfactant performance.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cholesterol; ESR; Exogenous pulmonary surfactant; Serum lipoproteins; Structural changes

Mesh:

Substances:

Year:  2013        PMID: 23994827     DOI: 10.1016/j.resp.2013.08.004

Source DB:  PubMed          Journal:  Respir Physiol Neurobiol        ISSN: 1569-9048            Impact factor:   1.931


  1 in total

1.  Association between high-density lipoprotein cholesterol level and pulmonary function in healthy Korean adolescents: the JS high school study.

Authors:  Ji Hye Park; Seyeon Mun; Dong Phil Choi; Joo Young Lee; Hyeon Chang Kim
Journal:  BMC Pulm Med       Date:  2017-12-11       Impact factor: 3.317

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.